Hydrocephalus Global Market Report 2024

The hydrocephalus market size has grown strongly in recent years. It will grow from $3.46 billion in 2023 to $3.63 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The increase observed in the historical period can be attributed to awareness of neurological disorders, advances in pediatric healthcare, an increased incidence of traumatic brain injuries, improved access to healthcare, and research and development initiatives.

The hydrocephalus market size is expected to see strong growth in the next few years. It will grow to $4.44 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The expansion anticipated in the forecast period can be linked to advancements in neuroendoscopy, a growing geriatric population, regulatory support for medical devices, an increase in traumatic brain injuries, and global health initiatives. Major trends projected for the forecast period encompass an increased focus on pediatric neurology, technological innovations in shunt systems, advancements in medical technology, innovations in surgical techniques, and advancements in shunt technologies.

The hydrocephalus market is experiencing significant growth due to the increased prevalence of hydrocephalus. This medical condition, characterized by the accumulation of cerebrospinal fluid in the brain cavities, is becoming more prevalent, particularly among different age groups. According to a report published by the National Center for Biotechnology Information, the global prevalence of hydrocephalus is reported to be around 85 per 100,000 people, with notable variations between age groups. The increasing prevalence, especially among the senior population, is expected to drive the growth of the hydrocephalus market.

The hydrocephalus market is expected to witness significant growth driven by the rapid expansion of healthcare infrastructure. Healthcare infrastructure, comprising buildings, organizations, and resources dedicated to health, is crucial for providing comprehensive treatment for hydrocephalus. Investments in healthcare infrastructure, as reported by the Department of Health and Aged Care, are expected to reach an all-time high, contributing to improved outcomes for individuals suffering from hydrocephalus.

Technological advancements are the key trend embraced by premier players. Major companies are developing advanced technological devices for the treatment of hydrocephalus. For example, Cranial Devices Inc., a US-based start-up from Pennsylvania State University, advanced the HydroFix device in June 2021. This high-tech shunt system involves a cerebrospinal fluid (CSF) drain to address significant clinical needs and reduce risks associated with surgical shunt failure in hydrocephalus treatment.

Premier companies in the hydrocephalus market are developing innovative products, such as non-invasive medical devices, to enhance product offerings and gain a competitive advantage. A non-invasive medical device is a form of medical equipment or technology that does not require skin penetration, bodily orifices, or the removal of any human tissue to be used. Anuncia Medical, Inc., a US-based medical equipment manufacturing company, received FDA approval for the ReFlow System Mini in September 2022. Recommended for noninvasive ventricular catheter flushing in hydrocephalus patients, this device may be used in-clinic or by certified caregivers or adult patients at home under the guidance of a treating physician.

In January 2022, ICU Medical Inc., a US-based manufacturing company of valves, acquired Smiths Medical, Inc. for an undisclosed amount. Through this acquisition, Smiths Medical complements ICU Medical's existing company and creates a scalable US-based worldwide rival, strengthening the stability of the medical supply chain and having the potential to grow as clinical care models develop. Smiths Medical, Inc. is a US-based valve and diagnostics manufacturing company.

Major companies operating in the hydrocephalus market report are Johnson & Johnson Corporation, Thermo Fisher Scientific, Medtronic PLC, MIZUHO Co. Ltd., B. Braun Melsungen AG, Helios Hospital, Agilent Technologies Inc., Texas Children's Hospital, Boston Children’s Hospital, Karl Storz Se And Co. Kg, Integra LifeSciences Corporation, Children's National Hospital, Natus Medical Incorporated, Aesculap Inc., HLL Lifecare Limited, Sophysa SA, Anadolu Medical Center, Christoph Miethke GmbH & Co. KG, Alcyone Therapeutics Inc., Moller Medical GmbH, Spiegelberg GmbH & Co. KG, G. SURGIWEAR LTD., Tokibo Co. Ltd., HpBio Proteses Inc., Desu Medical, Dispomedica GmbH, Kaneka Medix Corporation, Delta Surgical Limited.

North America was the largest region in the hydrocephalus market in 2023. The regions covered in the hydrocephalus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hydrocephalus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of hydrocephalus include congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, and ex-vacuo hydrocephalus. Congenital hydrocephalus results from birth abnormalities or brain malformations, leading to excessive cerebrospinal fluid (CSF) accumulation. Hydrocephalus can be pediatric or adult, detectable through MRI, CT scans, head ultrasound, and others, with end-users including hospitals, diagnostic centers, academic institutions, and research organizations.

The hydrocephalus market research report is one of a series of new reports that provides hydrocephalus market statistics, including hydrocephalus industry global market size, regional shares, competitors with a hydrocephalus market share, detailed hydrocephalus market segments, market trends and opportunities, and any further data you may need to thrive in the hydrocephalus industry. This hydrocephalus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hydrocephalus market consists of sales of shunts, valves, and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.